The Inflation Reduction Act (IRA) offered many improvements to Medicare Part D coverage, and the following are highlights that will be in place for the 2026 plan year.
Please note: the actual drug plan options and 2026 benefits will be available for review beginning October 1, 2025.
The new Inflation Reduction Act (IRA) updated what counts towards True out-of-pocket (TrOOP) costs in 2026. TrOOP includes costs you pay out of pocket (e.g., your deductible, copays, and coinsurance) and some payments made on your behalf.
Most drug plans will release their 2026 plan benefits to the public by late September 2025.
Medicare has negotiated and finalized drug pricing directly with manufacturers for the following high-tier medications. Prices for the following 10 drugs will likely be effective Jan 1, 2026. More info available here.
Under the Inflation Reduction Act, covered insulin received reduced cost-sharing for many Medicare beneficiaries with a cap on what you pay for monthly insulin supplies. It also required insulin to be covered before you meet your deductible.
Starting in January 2026, this cap becomes more flexible and may increase savings for Medicare enrollees. You will pay the lesser of:
The Medicare prescription payment plan was introduced in 2025, and will also be available in 2026.
Copyright © 2025 Waxman Insurance - All Rights Reserved.
Not connected with or endorsed by the United States government or the federal Medicare program. We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-medicare to get information on all of your options.